Nonlinear Computation Tool to Chart Trajectories of Bipolar Disorder
用于绘制双相情感障碍轨迹的非线性计算工具
基本信息
- 批准号:9061019
- 负责人:
- 金额:$ 64.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-03-15 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:BehavioralBipolar DepressionBipolar DisorderChaos TheoryChronicChronic DiseaseClinicClinicalClinical ResearchClinical TrialsCognitionComplexComputer softwareConsentDataData SecurityDevelopmentDirect CostsDiseaseDoctor of MedicineDoctor of PhilosophyEconomic BurdenEconomicsEffectivenessEnrollmentEnsureFacilities and Administrative CostsFocus GroupsFundingGoalsHealthHealth Care CostsHealth Care ResearchHealth Insurance Portability and Accountability ActHealth PersonnelHealth ProfessionalHealth SciencesHealth Services AccessibilityHealthcareImprove AccessIndividualInformation ResourcesInternetLeadManualsMeasuresMethodologyMoodsMorbidity - disease rateNational Institute of Mental HealthOhioOnline SystemsOperating SystemOutcomeParticipantPatientsPerformancePersonal ComputersPharmaceutical PreparationsPhasePremature MortalityPrincipal InvestigatorProviderPsyche structurePsychiatristPublic HealthRandomizedRecurrenceRegulationReportingResearch PersonnelRisk BehaviorsRoleSamplingSelf ManagementSelf PerceptionSeveritiesSiteSmall Business Technology Transfer ResearchSoftware EngineeringSoftware ToolsSoftware ValidationSourceSuggestionSymptomsSystemSystems TheoryTechnologyTestingTexasTimeTreatment EfficacyUniversitiesVisitanalytical toolbasebiomedical informaticsbipolar patientscommercializationcomputerized toolscostdesigndisabilityexperiencefield studyhandheld mobile devicehealth information technologyimprovedimproved outcomeinnovationmHealthmeetingsmobile applicationmood symptomnovelpatient orientedphase 1 studyphase 2 studyprogramsprototypequality assurancesoftware developmentsoftware systemssuccesssymptomatic improvementtoolusabilityuser centered design
项目摘要
DESCRIPTION (provided by applicant): Bipolar disorder (BD) is a complex chronic illness characterized by recurrent, often dramatic mood changes. Self-management of BD is an important component of treatment, but is likewise complex and can be fraught with difficulties including misunderstanding of the condition and a lack of self-awareness. Combined with the nationwide shortage of mental healthcare providers and the advent of the Affordable Healthcare Act, patients are assuming an increased role in understanding and managing their chronic conditions. At the same time, the emergence of mobile health and computational tools are engaging patients in self- management by enabling timely access to information and resources. The goal of this project is to complete the development of a patient-centered software system and mobile app to assist in managing bipolar disorder. In Phase I, we developed a novel computational tool known as KIOS. Based on concepts from nonlinear systems (chaos) theory, KIOS tracks multiple interacting symptoms to determine the precise state of a BD patient. Once the patient's state is identified and the trajectory of the patient is established, KIOS produces advice specific to the patient's condition to help manage the course of the disease. To demonstrate the usability of the software, KIOS was converted to an online tool with mobile access. Twenty bipolar patients evaluated KIOS in a twelve week field trial. No technical problems with the software were observed and results showed that patients had significantly more reductions in symptom severity than increases. The development of this innovative tool to help patients self-manage BD has the potential to have a profound impact on public health and achieve significant commercial success. This Phase II study has three Specific Aims: Specific Aim 1. Refine Prototype Software Specific Aim 2. Evaluate KIOS in a Randomized, Open 16 week Effectiveness Study Specific Aim 3. Integrate Data Security and Establish Quality Standards
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder.
开发以患者为中心的软件系统,以促进双相情感障碍的有效管理。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Bowden,CharlesL;Priesmeyer,Richard;Tohen,Mauricio;Singh,Vivek;Calabrese,JosephR;Ketter,Terry;Nierenberg,Andrew;Thase,MichaelE;Siegel,Gregg;Siegel,LeslieH;Mintz,Jim;El-Mallakh,RifS;McElroy,SusanL;Martinez,Melissa
- 通讯作者:Martinez,Melissa
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES LEE BOWDEN其他文献
CHARLES LEE BOWDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES LEE BOWDEN', 18)}}的其他基金
Calcium Study of Lymphoblasts in Bipolar Patients to Aid Diagnosis and Treatment
双相情感障碍患者淋巴细胞的钙研究有助于诊断和治疗
- 批准号:
8462688 - 财政年份:2012
- 资助金额:
$ 64.62万 - 项目类别:
Calcium Study of Lymphoblasts in Bipolar Patients to Aid Diagnosis and Treatment
双相情感障碍患者淋巴细胞的钙研究有助于诊断和治疗
- 批准号:
8283631 - 财政年份:2012
- 资助金额:
$ 64.62万 - 项目类别:
Nonlinear Computation Tool to Chart Trajectories of Bipolar Disorder
用于绘制双相情感障碍轨迹的非线性计算工具
- 批准号:
8125705 - 财政年份:2011
- 资助金额:
$ 64.62万 - 项目类别:
Optimizing Outcomes in Bipolar Illness Interventions in Hispanic Communities
优化西班牙裔社区双相情感障碍干预的结果
- 批准号:
8100769 - 财政年份:2011
- 资助金额:
$ 64.62万 - 项目类别:
Optimizing Outcomes in Bipolar Illness Interventions in Hispanic Communities
优化西班牙裔社区双相情感障碍干预的结果
- 批准号:
8335401 - 财政年份:2011
- 资助金额:
$ 64.62万 - 项目类别:
Optimizing Outcomes in Bipolar Illness Interventions in Hispanic Communities
优化西班牙裔社区双相情感障碍干预的结果
- 批准号:
8533805 - 财政年份:2011
- 资助金额:
$ 64.62万 - 项目类别:
Optimizing Outcomes in Bipolar Illness Interventions in Hispanic Communities
优化西班牙裔社区双相情感障碍干预的结果
- 批准号:
8730218 - 财政年份:2011
- 资助金额:
$ 64.62万 - 项目类别:
Nonlinear Computation Tool to Chart Trajectories of Bipolar Disorder
用于绘制双相情感障碍轨迹的非线性计算工具
- 批准号:
8240987 - 财政年份:2011
- 资助金额:
$ 64.62万 - 项目类别:
Bipolar Illness Intervention in Hispanic Communities
西班牙裔社区双相情感障碍干预
- 批准号:
7929270 - 财政年份:2009
- 资助金额:
$ 64.62万 - 项目类别:
相似海外基金
Psilocybin Assisted Psychotherapy for Bipolar Depression: An fMRI Emotional-Processing Pilot Study
裸盖菇素辅助双相抑郁心理治疗:功能磁共振成像情绪处理试点研究
- 批准号:
486939 - 财政年份:2023
- 资助金额:
$ 64.62万 - 项目类别:
Miscellaneous Programs
Repeated Ketamine Infusions for Cognitive Impairment in Treatment-Resistant Bipolar Depression
反复输注氯胺酮治疗难治性双相抑郁症的认知障碍
- 批准号:
486443 - 财政年份:2022
- 资助金额:
$ 64.62万 - 项目类别:
Studentship Programs
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study
裸盖菇素对治疗难治性双相抑郁症的神经生物学作用:情绪处理功能磁共振成像初步研究
- 批准号:
486577 - 财政年份:2022
- 资助金额:
$ 64.62万 - 项目类别:
Studentship Programs
Reward and stress: Developing neuroimaging biomarkers for bipolar depression
奖励和压力:开发双相抑郁症的神经影像生物标志物
- 批准号:
2748645 - 财政年份:2022
- 资助金额:
$ 64.62万 - 项目类别:
Studentship
Theta-burst stimulation for bipolar depression: A randomized controlled trial
θ 爆发刺激治疗双相抑郁症:一项随机对照试验
- 批准号:
469571 - 财政年份:2022
- 资助金额:
$ 64.62万 - 项目类别:
Operating Grants
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
大麻二酚辅助治疗急性双相抑郁症:随机双盲安慰剂对照试验
- 批准号:
444068 - 财政年份:2021
- 资助金额:
$ 64.62万 - 项目类别:
Operating Grants
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized, Midazolam-Controlled Phase II Clinical Trial
重复氯胺酮输注治疗难治性双相抑郁症:一项随机、咪达唑仑对照的 II 期临床试验
- 批准号:
434675 - 财政年份:2020
- 资助金额:
$ 64.62万 - 项目类别:
Operating Grants
Next Generation Drugs for Bipolar Depression and Maintenance
治疗双相抑郁症和维持治疗的下一代药物
- 批准号:
9555300 - 财政年份:2018
- 资助金额:
$ 64.62万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10080262 - 财政年份:2018
- 资助金额:
$ 64.62万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10588254 - 财政年份:2018
- 资助金额:
$ 64.62万 - 项目类别:














{{item.name}}会员




